Treatment Response Biomarkers in Asthma and COPD
Chronic obstructive pulmonary disease (COPD) and asthma are two of the most common chronic diseases worldwide. Both diseases are heterogenous and complex, and despite their similarities, they differ in terms of pathophysiological and immunological mechanisms. Mounting evidence supports the presence...
Main Authors: | Howraman Meteran, Pradeesh Sivapalan, Jens-Ulrik Stæhr Jensen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/9/1668 |
Similar Items
-
Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma
by: Barbara Bonnesen, et al.
Published: (2022-06-01) -
A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study
by: Ji-Su Shim, MD, PhD, et al.
Published: (2023-12-01) -
Recent developments in the management of severe asthma
by: Howraman Meteran, et al.
Published: (2022-03-01) -
Time-Updated Phenotypic Guidance of Corticosteroids and Antibiotics in COPD: Rationale, Perspective and a Proposed Method
by: Alexander Jordan, et al.
Published: (2023-05-01) -
The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma–COPD Overlap Syndrome
by: Pérez de Llano L, et al.
Published: (2022-03-01)